# Crocin Supplementation in CSCR

> **NCT04936490** · PHASE1 · UNKNOWN · sponsor: **Shiraz University of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Chorioretinopathy, Central Serous

## Interventions

- **DRUG:** Crocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04936490
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04936490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04936490, "Crocin Supplementation in CSCR". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04936490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*